Healthcare Services

Autoimmune Treatment Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Autoimmune Treatment Market In 2026 And What Value Is Projected For 2030?

The autoimmune treatment market size has seen rapid growth in recent years. It is anticipated to expand from $8.63 billion in 2025 to $9.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.0%. The expansion observed in prior periods can be attributed to improved accessibility of immunosuppressive drugs, the development of rheumatology and immunology services, an increase in clinical experience concerning autoimmune care, higher rates of patient diagnosis, and more extensive access to specialty medications.

The autoimmune treatment market size is anticipated to experience swift expansion in the upcoming years. It is projected to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This projected growth can be attributed to increased investment in developing novel biologics, a rising demand for tailored autoimmune therapies, the broadening of digital monitoring and follow-up care services, an intensified focus on reducing long-term disease complications, and augmented research into immune system modulation. Significant trends expected during this forecast period involve a greater adoption of biologic therapies, an increasing utilization of targeted immunomodulators, the growing integration of long-term disease management programs, an expansion of personalized treatment regimens, and an enhanced focus on combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

What Key Drivers Are Influencing The Growth Of The Autoimmune Treatment Market?

The anticipated increase in healthcare spending is set to stimulate expansion within the autoimmune treatment market in the future. Healthcare expenditures encompass all expenses linked to delivering health services, family planning initiatives, nutritional schemes, and health-focused emergency assistance. An uptick in healthcare spending is projected to foster the creation of improved therapies and advanced medical technologies specifically for autoimmune conditions. For example, projections from the Office for Budget Responsibility (OBR) and Treasury indicate that the UK’s planned health expenditure is forecasted to climb to £192 billion ($244.43 billion) in 2024/25, rising from £182 billion ($231.70 billion) recorded in 2022/23. Likewise, data from the National Health Expenditures Accounts (NHEA) by KFF, an independent health policy research organization based in the US, suggests that health spending in the United States is expected to expand by 5% from 2023 to 2024, eventually reaching $4.9 trillion. Consequently, the increase in healthcare expenditures is a key impetus behind the expansion of the autoimmune treatment market.

What Are The Key Segments Of The Autoimmune Treatment Market?

The autoimmune treatment market covered in this report is segmented –

1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development

2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention

Subsegments:

1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification

2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs

3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance

Which Market Trends Are Creating New Opportunities In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are increasing their emphasis on introducing innovative clinical trial platforms to gain a competitive advantage. These novel clinical trial platforms in autoimmune treatment leverage advanced technologies and personalized methods to enhance efficacy, safety, and patient outcomes. For instance, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, launched the CONQUEST trial platform. The CONQUEST program aims to advance research and treatments for scleroderma, a rare autoimmune disease that affects connective tissues. It addresses critical issues in clinical development and facilitates advancements in scleroderma therapeutics. The CONQUEST platform clinical trial is the first of its kind in rare autoimmune diseases, designed to quickly evaluate potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD), as well as global SSc outcomes, including those focused on skin and other aspects of the disease.

Who Are The Leading Companies Operating In The Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited

Read the full autoimmune treatment market report here:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autoimmune Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company

Autoimmune Disease Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Veterinary Autoimmune Disease Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-autoimmune-disease-therapeutics-global-market-report

Systemic Lupus Erythematosus Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795